Comparison of Point-Of-Care testing and venouS blood glucose at the oral Glucose TolerAnce test in pRegnancy
- Conditions
- Gestational Diabetes, Pregnancy
- Registration Number
- NL-OMON24013
- Lead Sponsor
- Zuyderland Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 330
Inclusion Criteria
12-40 weeks pregnant
Indication for OGTT
Exclusion Criteria
Unable to read informed consent in Dutch or English
Pre-gestational diabetes mellitus (type I or II)
Using glucose lowering medication (for example Metformin or Glyburide)
History of bariatric surgery with dumping in the past
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of agrement between plasma levels and capillary samples.
- Secondary Outcome Measures
Name Time Method To determine the number of diagnosed patients with GDM detected by POCT. <br>To evaluate whether adjusted cut-offs for the POCT can be found to minimize false-positive and false-negative results compared to venous blood sampling.